chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started experiencing chills, sore throat, headache, pains in my legs and arms when laying down or walking around, and felt nauseous and lethargic. This would be random times in the day where the symptoms would get worse and I would have to lay down. I would have chest and abdominal pains, loss of appetite, and short cough that would come and go. I sometimes had phlegm. I decided to go to a facility to get COVID-19 PCR tested on 01/25/2022, and it came back positive. I stayed home and isolated for 5 days. I then began suffering post-symptoms in February. I started getting random bruises and pains in my arms, legs, and chest. I would get extremely exhausted and thought I was low on iron. So I would eat a banana and take iron and zinc, but that wasn't helping. So I would take Tylenol and ibuprofen to try to take the pain away, but it wasn't helping at all. It would drown out the pain, but not take it away completely. I went to the emergency room; they told me I was at risk for blood clots after taking blood work. They told me to double my dose of ibuprofen to manage the pain and prevent blood clots. Since that recommendation, it's helped a lot with managing the pain and the random bruising.
This case was reported by a healthcare professional and described the occurrence of erythema of arm at injection site in a 68-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline), (non-gsk) PNEUMOVAX. Concurrent medical conditions included allergic to sulfur. Historic vaccination included BOOSTRIX; GlaxoSmithKline; unknown; unknown given in February 2013. Concurrent medications included METFORMIN and CRESTOR. On 21 January 2014 the subject received 2nd dose of BOOSTRIX (unknown details, unknown arm), unspecified dose of PNEUMOVAX (unknown details) and experienced extra dose administered. Per the reporter, the subject "was given 2 doses of BOOSTRIX in an eleven month period." BOOSTRIX is indicated as one dose. On 21 January 2014, described as "evening time", within hours of vaccination with BOOSTRIX and PNEUMOVAX, the subject experienced erythema of arm at injection site (described as "redness in arm"). It was unclear from the report as to the specific locations of administration of two vaccinations. At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the events were possibly related to vaccination with BOOSTRIX. It was unclear from the report if the healthcare professional considered the events related to PNEUMOVAX.
has crohn's; falling asleep/ came home and slept/walking coma for three weeks; very letharhic; barely could function in school; This case was reported by a consumer via interactive digital media and described the occurrence of crohn's disease in a child male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, less than a day after receiving Meningococcal B vaccine, the patient experienced crohn's disease (serious criteria GSK medically significant), sleepiness, lethargy and activities of daily living impaired. On an unknown date, the outcome of the crohn's disease was unknown and the outcome of the sleepiness, lethargy and activities of daily living impaired were recovered/resolved.   It was unknown if the reporter considered the crohn's disease, sleepiness, lethargy and activities of daily living impaired to be related to Meningococcal B vaccine.  Additional information was provided as follows: The age at vaccination was not reported. The day of patietnt's doctor visit, the patient was talking, walking, active mentally and physically. The patient was in a near walking coma for three weeks after vaccination. After the shot, by the time they hit the car, the patient was almost falling asleep, very lethargic, he was like that for three weeks, barely could function in school, came home and slept. But of course doctor said it could not be the vaccine and at the time of reporting, the patient had crohn's, an autoimmune disease. The reporter stated the vaccines were not what they were cracked up to be.
Systemic: Fainting / Unresponsive-Medium, Additional Details: pt became very dizzy and almost fainted, she went to er after by personal vehicle
I got the shivers which were so extreme I had to hold my jaw shut to not break my teeth. This lasted about two hours and then slowly went into a fever for a two hours and then I relaxed.
Information has been received from a 33 year old female with no past medical history and no known drug allergies who on 15 AUG 2001 was vaccinated with a dose of hepatitis b vaccine recombinant (yeast). Concomitant therapy that day included a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (MSD) and varicella virus vaccine live (site unknown) (MSD). Other concomitant therapy included unspecified steroids (manufacturer unknown). After being vaccinated, the patient began feeling tired and her head was "feeling heavy". It was reported that the patient's symptoms were "decreasing" since she received the vaccines. The patient sought unspecified medical attention. Additional information has been requested.
PATIENT IS FEELING NAUSEATED, GIVEN AN ICE PACK AND HAS BEEN SEATED IN THE OFFICE WITH MEDICAL STAFF FOR THE LAST HOUR.
An initial report was received in the USA from a health care professional on 7/15/05. A 16 year old female patient complained of headache and joint pain of knees and elbows seven days after she had received SC injection of Menactra, lot number U1641AA, in the left arm. The vaccine was admnistered SC in stead of IM. She was treated with Motrin and her symptoms resolved. Follow-up information received on 30-August-2005. The patient received the vaccine on 10-June-2005 at 10:00 and the adverse events started 7 days later at 13:00. The patient also received MOTRIN concomitantly.
pt recv vax; devel aching in jaw,nasal stuffiness,recurrent ear & throat pain & cervical adenitis;29jul94,cont to exp the upper resp congestion;flu-like sx of myalgia & gene malaise; 1sep94 recovered;
arm was itchy; arm was warm to the touch; Aching arm; arm was red from her shoulder to her elbow; bit sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch), PAIN IN EXTREMITY (Aching arm), ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy and Drug allergy (Dilaudid, her throat started to close (post-surgery for hip replacement).).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch), PAIN IN EXTREMITY (Aching arm), ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site). At the time of the report, PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch) and PAIN IN EXTREMITY (Aching arm) outcome was unknown and ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided by the reporter. Patients doctor immediately put her on an antibiotic in case of cellulitis
stomach was a little upset; very tired; her heart rate is a little higher, like 95; she feels like nausea; tongue was tingling a little bit; whole body was tingling; headache; her tongue feels like it is tingling and dry; has pain in her right hand since she got the vaccine dose in her right upper arm; feeling a little bit febrile, her temperature was 99 degrees Fahrenheit; This is a spontaneous report from contactable consumers.  A 45-year-old female patient receive the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EC1283, via an unspecified route of administration in the right arm, on 24Jan2021 17:00 at SINGLE DOSE for covid-19 immunization.  Medical history included blood pressure, and on birth control. She recently started taking the blood pressure medication (lisinopril) three months ago her blood pressure was due to a lot of stress, and she was not feeling good she had her doctor to see her blood pressure her doctor then put her on this (lisinopril). She stated that she took Lisinopril 5mg at night last night as well as took her birth control pill. Concomitant medication included lisinopril for blood pressure; ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE), pantoprazole and an unspecified flu shot injection to arm in October (year not specified; she takes the flu shot every year).  The patient received BNT162B2 on an unspecified date for covid-19 immunization; on the first dose of COVID-19 vaccine, she felt nothing, just a little tired and she had pain in her left hand. However, it was different for the second dose. Fifteen (15) minutes after getting her second dose of vaccine, the patient was fine. Then after 30 minutes, she came home and felt like her whole body was tingling, and her tongue was tingling a little bit. She says she did drink some water. She did no treatment other than drink some water and take and hold breath in and out, holding her breath a little bit. She says her body was tingling for just a second, that is gone, her tongue feels like it is tingling and dry, kind of like when you taste something spicy a little bit, that kind of experience. She says that it lasted like 1- 2 hours yesterday and it is not going, she still feels it a little bit on her tongue, the rest of her body is not tingling. She also experienced headache and has pain in her right hand since she got the vaccine dose in her right upper arm. Today(25Jan2021),  she was feeling very tired, her heart rate was a little higher, like 95, and she was feeling something like nausea, her stomach was a little upset today, and she was feeling a little bit febrile, her temperature was 99 degrees Fahrenheit when she took it. Outcome of events was reported as 'unknown'.  No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.
"Woke up this morning with blurred vision"; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810) via an unspecified route of administration in the left arm on 14May2021 at 15:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: fN6207) via an unspecified route of administration in the left arm on 23Apr2021 at 15:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:15, the patient woke up this morning (the day after the vaccination) with blurred vision. The patient sometimes uses reading glasses to see smaller print but this was different. The patient could not see words on the TV clearly, that he usually had never had a problem reading and everything was blurred even with reading glasses. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event "woke up this morning with blurred vision" was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient called the morning after to report arm stiffness and limited mobility. I checked with doctor's office and medical assistant said she called the patient and confirmed it was just muscle soreness from IM injection. When I called patient to check up on him again he said he was feeling a lot better and arm was not as stiff.
Headache, Myalgia, Fever, chills, bodyaches Narrative: Employee stated woke up this morning with headache, extreme chills and body aches
Vaccine give too soon Hep 2/3 not spaced AHAVB093BA IM 2 months apart 2 doses previous.
This case was reported by a healthcare professional and described the occurrence of injection site redness in a female subject of unspecified age who was vaccinated with Flulaval (GlaxoSmithKline).  On an unspecified date in 2007 (between 18 September 2007 and 02 October 20007), the subject received unspecified dose of Flulaval (0.5 ml, unknown, left arm).  On the same date as vaccination with Flulaval, the subject experienced injection site redness, injection site pruritus, and swelling injection site.  Medical attention was required at the doctor's office.  The events were resolved on the same of vaccination/ onset of the adverse events.  The healthcare professional considered the events were probably related to vaccination with Flulaval.  The nurse reported a total of four subjects who experienced similar reactions following administrations of Flulaval between 18 September 2007 and the time of reporting on 02 October 2007 (please see GSK reference numbers A0686378A, A0686379A, and A0686380A).  "Some" of the subjects experienced "swelling at the site of injection to about softball size".  The subjects had previously received influenza vaccinations and had not experienced adverse reactions "other than one patient who may have experienced redness at injection site".
This case was reported by a consumer via call center representative and described the occurrence of shivering in a 67-year-old male patient who received SHINGRIX for prophylaxis. On 30th January 2019, the patient received the 1st dose of SHINGRIX. In January 2019, less than a day after receiving SHINGRIX, the patient experienced shivering, fever and sleeplessness. The patient was treated with TYLENOL. On an unknown date, the outcome of the shivering, fever and sleeplessness were unknown. It was unknown if the reporter considered the shivering, fever and sleeplessness to be related to SHINGRIX. Additional details were provided as follows: The patient felt as if he had a fever, extreme shivering but no sweating. The patient took a couple of TYLENOL and the chills subsided but he got no sleep. In the morning of reporting day, felt more or less but was okay, but hammered (almost no sleep).
Was feeling achy and had headache day prior but after shower at about 11:00 am on 02/26/2021 started feeling strange. My hands and feet got tingly and then while I was on the phone my tongue and throat swelled and unable  to speak and started to cough. But couldn?t clear my throat . I was able to get enough oxygen. My husband drove my to ER and which time they took my straight back took my vitals and gave me Benadryl, Pepcid, and steroid injection and it worked! They observed me few hours and sent me home.  I was unable to sleep  last night and a hallucination that concerned my husband but otherwise  I?m just achy today, note I never had a fever.
PFIZER vaccine that was stored in pharmacy refrigerator given outside of 31 day expiration. Vaccine received at hospital on 11/19/2021. Expiration date on vial 02/2022.  59267100001
Pt immediately became lightheaded post administating MMR, Pt was cold & skin was clammy. Pt was instructed to lie on back, cold compresses was applied to neck & face. Pulse & BP were monitored Pt has symptoms X 10 minutes
diabetic; sugar level went to 66; shaking; dizziness; fatigue; This is a spontaneous report from a contactable consumer reporting for herself. A 77-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EK9231), via an unspecified route of administration, on 23Jan2021 at 13:15, at single dose, for COVID-19 immunisation. Medical history included drug allergy (to epinephrine), diabetes, chronic obstructive pulmonary disease (COPD), arthritis. Patient did not have COVID-19 prior to vaccination. Concomitant medications included glipizide (unknown manufacturer), losartan (unknown manufacturer), lovastatin (unknown manufacturer), metformin hydrochloride (MEDFORMIN), meloxicam (unknown manufacturer). The patient experienced diabetic, sugar level went to 66, shaking, dizziness and fatigue all on 24Jan2021 at 11:00 with outcome of not recovered. The patient underwent lab tests and procedures which included blood glucose: 66 on 24Jan2021, 88 on 24Jan2021, 360 on 24Jan2021, 186 on 25Jan2021. On 24Jan2021 it was reported that sugar level went to 66. She ate sugar, level went to 88, ate more sugar level went to 360. Therapeutic measures were taken as a result of diabetic and sugar level went to 66 and included sugar. No therapeutic measures were taken as a result of the other events. Patient was not tested for COVID-19 post vaccination.  The information on the lot/batch number has been requested.
(L) hand and finger tingling feels like pinpricks. Hurt when vaccine entered muscle and not needle stick.
Patient began experiencing "lightning bolt" pains in the temporal region of her head.  Debilitating and completely prostrating migraine headaches which lasted up to 4 days at a time.  She was treated with Imitrex and Motrin 800 mg, and felt no relief.  She also experienced blindness in her left eye, and numbness and tingling in her extremities.  Then she began experiencing fatigue, anger, and dizziness.  After nine months of these symptoms, the symptoms progressed, and she began experiencing all of the above, with deja vu spells, associated with bitter tastes and smells, as well as memory loss.  The partial seizures, and lightning bolt headaches continued for several years, and then, on May 8, 2010, she experienced a grand mal seizure, and another on July 10, and September 14, and December 14.  Treatment began in December, 2010 after she was officially and finally diagnosed with seizures.  Keppra 750mg BID.  Patient experienced at times as many as 6 partial seizures per day, but now averages one per every two weeks.  Lightning bolt headaches are daily.
Itching, still itches; Red blotchy large circle at site of injection; This case was reported by a consumer via interactive digital media and described the occurrence of injection site itching in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. In November 2021, 5 days after receiving Shingles vaccine, the patient experienced injection site itching and injection site erythema. The patient was treated with calamine + zinc oxide (Calamine Lotion). On an unknown date, the outcome of the injection site itching was not recovered/not resolved and the outcome of the injection site erythema was recovered/resolved.   It was unknown if the reporter considered the injection site itching and injection site erythema to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had a Shingles shot about a month ago from reporting date and 5 days after vaccination he/she started itching and red blotchy large circle at the site of injection and still had month later somewhat itches during the day just not blotchy red circle anymore, so the patient rubbed calamine lotion on it when he/she felt the itch. In May 2022, the patient supposed to went back for 2nd part of the shot but not sure if he/she would. The follow-up could not be possible as no contact details were available.
Loose stools; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Loose stools) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Loose stools). At the time of the report, DIARRHOEA (Loose stools) outcome was unknown.            No concomitant medications were provided.  No treatment information provided.   Reporter did not allow further contact;
It was fever highest temperature was 102.4, chills, shaking chills at night time, intermittent night time cough, nasal congestion and fatigue. Tested positive on 04/17/2022. I am somewhat recovered, some nasal congestion and some fatigue. I typically walk 5 miles per day and I am only to do a mile and a half, getting better every day. No issues concentrating or inability to perform mental tasks, just the other symptoms.
The client states that she received Pneumovax vaccine on 12/04/01 at approx. 14:30. She states that the swelling began at approx. 18:00 on 12/04/01 and has gotten progressively worse. Her right upper arm is reddened, markedly swollen, warm and tender to touch. The client denies itching at this time but states it was itching last night. She has used Cortaid cream and ice packs with minimal relief.
The patient received the Janssen vaccine on Thurs. 04/08/21.  Friday, 04/09/21 the patient work up and has a big red welt at the injection site.  The welt is hot to touch and itchy.   The patient was instructed to take benedryl PO.
feels very sick; headache; lethargic; swelling in ankle; pain in both knees; rash on injectionsite at shoulder; Pain in lower back; Pain in neck joints; Pain in neck joints; This is a spontaneous report from a contactable other HCP (Patient) received from Pfizer sponsored program. A 57-year-old female patient received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot Number was not reported) via an unspecified route of administration on 31Mar2021 as dose 1, single for COVID-19 immunization. The patient's medical history included rash, psoriasis, joint swelling, from unspecified date if ongoing, patient took 3 epidural injections in back during october/november/december of 2020. The patient's concomitant medications were not reported. It was reported that, preexisting condition improved after start of therapy: rash and psoriasis/pain and swelling in joints. Patient xeljanz was on hold since 26MAR2021, took 1st covid vaccine on 31MAR2021, 2nd one on 28APR2021 and would restart on 12MAY2021. After 1st dose of vaccine, on an unspecified date in Apr2021 patient experienced feels very sick, headache, lethargic, swelling in ankle, pain in both knees, rash on injection site at shoulder, pain in lower back, pain in neck joints which were subsided after start of therapy. Then patient received BNT162B2 (COMIRNATY, formulation: solution for injection, Lot Number was not reported) via an unspecified route of administration on 28APR2021 as dose 1, single for COVID-19 immunization. The outcome of all events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Patient given DTap in error, should have received Tdap booster. Received  Dtap on 11/3/07